These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 19791423

  • 1. Proteasome inhibition: mechanism of action.
    DeMartino GN.
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
    [Abstract] [Full Text] [Related]

  • 2. Proteasome inhibition as a novel therapeutic target in human cancer.
    Rajkumar SV, Richardson PG, Hideshima T, Anderson KC.
    J Clin Oncol; 2005 Jan 20; 23(3):630-9. PubMed ID: 15659509
    [Abstract] [Full Text] [Related]

  • 3. Proteasome inhibition as a therapeutic strategy for hematologic malignancies.
    Mitsiades CS, Mitsiades N, Hideshima T, Richardson PG, Anderson KC.
    Expert Rev Anticancer Ther; 2005 Jun 20; 5(3):465-76. PubMed ID: 16001954
    [Abstract] [Full Text] [Related]

  • 4. Proteasome inhibitors as therapeutics.
    Mitsiades CS, Mitsiades N, Hideshima T, Richardson PG, Anderson KC.
    Essays Biochem; 2005 Jun 20; 41():205-18. PubMed ID: 16250907
    [Abstract] [Full Text] [Related]

  • 5. Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.
    Zaman F, Menendez-Benito V, Eriksson E, Chagin AS, Takigawa M, Fadeel B, Dantuma NP, Chrysis D, Sävendahl L.
    Cancer Res; 2007 Oct 15; 67(20):10078-86. PubMed ID: 17942942
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.
    Fahy BN, Schlieman MG, Mortenson MM, Virudachalam S, Bold RJ.
    Cancer Chemother Pharmacol; 2005 Jul 15; 56(1):46-54. PubMed ID: 15791457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
    Meister S, Schubert U, Neubert K, Herrmann K, Burger R, Gramatzki M, Hahn S, Schreiber S, Wilhelm S, Herrmann M, Jäck HM, Voll RE.
    Cancer Res; 2007 Feb 15; 67(4):1783-92. PubMed ID: 17308121
    [Abstract] [Full Text] [Related]

  • 12. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.
    Anan A, Baskin-Bey ES, Isomoto H, Mott JL, Bronk SF, Albrecht JH, Gores GJ.
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct 15; 291(4):G709-16. PubMed ID: 16798723
    [Abstract] [Full Text] [Related]

  • 13. Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM).
    Yin D, Zhou H, Kumagai T, Liu G, Ong JM, Black KL, Koeffler HP.
    Oncogene; 2005 Jan 13; 24(3):344-54. PubMed ID: 15531918
    [Abstract] [Full Text] [Related]

  • 14. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Hussain AR, Al-Kuraya KS.
    Cancer Res; 2008 May 01; 68(9):3379-88. PubMed ID: 18451165
    [Abstract] [Full Text] [Related]

  • 15. Proteasome inhibition drastically but reversibly impairs murine lymphocyte development.
    Maseda D, Meister S, Neubert K, Herrmann M, Voll RE.
    Cell Death Differ; 2008 Mar 01; 15(3):600-12. PubMed ID: 18188168
    [Abstract] [Full Text] [Related]

  • 16. BCL-2 family regulation by the 20S proteasome inhibitor bortezomib.
    Fennell DA, Chacko A, Mutti L.
    Oncogene; 2008 Feb 21; 27(9):1189-97. PubMed ID: 17828309
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
    Tsukamoto S, Yokosawa H.
    Planta Med; 2010 Aug 21; 76(11):1064-74. PubMed ID: 20186654
    [Abstract] [Full Text] [Related]

  • 19. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
    Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C.
    J Cell Biochem; 2008 Jan 01; 103(1):270-83. PubMed ID: 17516511
    [Abstract] [Full Text] [Related]

  • 20. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
    Cvek B.
    Hum Reprod; 2009 Nov 01; 24(11):2967; author reply 2967-8. PubMed ID: 19687055
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.